{"id":"https://openalex.org/W7204483442","doi":"https://doi.org/10.7759/cureus.115287","title":"Successful Treatment of Palmoplantar Psoriasis With Bimekizumab Following Secondary Loss of Response to Brodalumab: A Case Report","display_name":"Successful Treatment of Palmoplantar Psoriasis With Bimekizumab Following Secondary Loss of Response to Brodalumab: A Case Report","publication_year":2026,"publication_date":"2026-08-27","ids":{"openalex":"https://openalex.org/W7204483442","doi":"https://doi.org/10.7759/cureus.115287","pmid":"https://pubmed.ncbi.nlm.nih.gov/42801085"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.115287","doi":"https://doi.org/10.7759/cureus.115287","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.115287","pdf_url":"https://www.cureus.com/articles/521491-successful-treatment-of-palmoplantar-psoriasis-with-bimekizumab-following-secondary-loss-of-response-to-brodalumab-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/521491-successful-treatment-of-palmoplantar-psoriasis-with-bimekizumab-following-secondary-loss-of-response-to-brodalumab-a-case-report.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051699181","display_name":"Priyanka Misra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priyanka Misra","raw_affiliation_strings":["Dermatology, St. Luke's Hospital, Leeds, GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, St. Luke's Hospital, Leeds, GBR","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065451603","display_name":"Nader Ghaderi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nader Ghaderi","raw_affiliation_strings":["Dermatology, St. Luke's Hospital, Leeds, GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, St. Luke's Hospital, Leeds, GBR","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.64556167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"8","first_page":"e115287","last_page":"e115287"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palmoplantar-psoriasis","display_name":"palmoplantar psoriasis","score":1.0},{"id":"https://openalex.org/keywords/bimekizumab","display_name":"bimekizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/secondary-loss-of-response","display_name":"secondary loss of response","score":0.8429999947547913},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.6819999814033508},{"id":"https://openalex.org/keywords/biologic-selection","display_name":"biologic selection","score":0.734000027179718},{"id":"https://openalex.org/keywords/plaque-clearance","display_name":"plaque clearance","score":0.4480000138282776},{"id":"https://openalex.org/keywords/psoriasis-flare","display_name":"psoriasis flare","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9905999898910522},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6912999749183655},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.5099999904632568},{"id":"https://openalex.org/C2909516574","wikidata":"https://www.wikidata.org/wiki/Q2562329","display_name":"Palmoplantar pustulosis","level":3,"score":0.289900004863739},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.27790001034736633},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.23559999465942383},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2304999977350235},{"id":"https://openalex.org/C3019417119","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Secondary prevention","level":2,"score":0.1964000016450882},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18970000743865967},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.18799999356269836}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.115287","doi":"https://doi.org/10.7759/cureus.115287","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.115287","pdf_url":"https://www.cureus.com/articles/521491-successful-treatment-of-palmoplantar-psoriasis-with-bimekizumab-following-secondary-loss-of-response-to-brodalumab-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmid:42801085","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42801085","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:13615726","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13615726/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13615726/pdf/cureus-0018-00000115287.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cureus","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.7759/cureus.115287","doi":"https://doi.org/10.7759/cureus.115287","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.115287","pdf_url":"https://www.cureus.com/articles/521491-successful-treatment-of-palmoplantar-psoriasis-with-bimekizumab-following-secondary-loss-of-response-to-brodalumab-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.4540817439556122,"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204483442.pdf","grobid_xml":"https://content.openalex.org/works/W7204483442.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2159058814","https://openalex.org/W2304028829","https://openalex.org/W2529389767","https://openalex.org/W2897043380","https://openalex.org/W3081361112","https://openalex.org/W3108872243","https://openalex.org/W4254993689","https://openalex.org/W4281877709","https://openalex.org/W4367301195","https://openalex.org/W4401176615","https://openalex.org/W4408273622","https://openalex.org/W4411604934","https://openalex.org/W7134263191"],"related_works":[],"abstract_inverted_index":{"Palmoplantar":[0,48],"psoriasis":[1,7,22,104,133],"is":[2,27],"a":[3,93,96,99,129,173],"rare":[4],"variant":[5],"of":[6,20,70,95,102,131,163,170,191,198,204],"localised":[8],"to":[9,165,196,208],"the":[10,35,47,68,125,168,188,202],"palms":[11],"and":[12,24,38,110,141,200],"soles.":[13],"The":[14],"condition":[15],"accounts":[16],"for":[17,81,122],"approximately":[18],"3%-4%":[19],"all":[21],"cases,":[23],"disease":[25,118,211],"severity":[26],"often":[28,79],"underestimated":[29],"by":[30],"traditional":[31],"measures":[32],"such":[33,60],"as":[34,61],"Psoriasis":[36,49],"Area":[37],"Severity":[39],"Index":[40],"(PASI)":[41],"score.":[42],"Other":[43],"assessment":[44],"tools,":[45],"including":[46],"Global":[50],"Assessment":[51],"(PPPGA)":[52],"score,":[53],"are":[54,78,194],"frequently":[55],"used":[56],"instead.":[57],"Topical":[58],"therapies":[59,74,112],"corticosteroids":[62],"or":[63],"vitamin":[64],"D":[65],"analogues":[66],"form":[67],"basis":[69],"initial":[71],"management.":[72],"Systemic":[73],"involving":[75],"biologic":[76,206],"agents":[77],"reserved":[80],"more":[82],"severe":[83],"cases":[84],"when":[85],"previous":[86],"treatment":[87,136,169],"options":[88],"have":[89],"failed.":[90],"We":[91],"report":[92],"case":[94,159],"woman":[97],"with":[98,113,128,135,154,187],"31-year":[100],"history":[101],"palmoplantar":[103,132,171],"who":[105],"had":[106],"previously":[107,178],"trialled":[108],"topical":[109],"systemic":[111],"minimal":[114],"response.":[115],"After":[116],"achieving":[117],"control":[119],"on":[120],"brodalumab":[121,140,166],"three":[123],"years,":[124],"patient":[126],"presented":[127],"flare":[130],"consistent":[134],"failure.":[137],"By":[138],"discontinuing":[139],"initiating":[142],"bimekizumab,":[143],"marked":[144],"improvement":[145],"in":[146,167],"plaque":[147],"clearance":[148,193],"was":[149],"observed":[150],"within":[151],"four":[152],"months,":[153],"no":[155],"adverse":[156],"effects.":[157],"This":[158],"presents":[160],"secondary":[161],"loss":[162,197],"efficacy":[164,199],"psoriasis,":[172],"phenomenon":[174],"that":[175,183],"has":[176],"not":[177],"been":[179],"reported.":[180],"It":[181],"highlights":[182],"even":[184],"biologics":[185],"associated":[186],"highest":[189],"rates":[190],"skin":[192],"susceptible":[195],"reinforces":[201],"importance":[203],"individualising":[205],"selection":[207],"achieve":[209],"long-term":[210],"control.":[212]},"counts_by_year":[],"updated_date":"2026-09-30T09:27:27.532063","created_date":"2026-08-28T00:00:00"}